Elligint Health Acquires Israeli AI Care Management Startup Laguna

Nov 12, 2026
US health insurer software provider Elligint Health is acquiring Laguna Health, whose AI records and assesses care management calls, in a deal reported at tens of millions of dollars.

Elligint Health, which sells care and utilisation management software to US health insurers, is acquiring Israeli startup Laguna Health, Calcalist reports. The value was not disclosed but is estimated at tens of millions of dollars.

Laguna's AI records conversations between insurer care teams and policyholders, runs quality checks, pulls out insights in real time and scores each interaction against the clinical and operational standards insurers must meet. The aim is to cut the time nurses and social workers spend on documentation.

Laguna, founded in 2020 by Yoni Stein and Yael Peled-Adam, has raised about $30 million from investors including Pitango, LionBird, SemperVirens and HC9. It will run as a wholly owned subsidiary and Elligint's AI development arm in Tel Aviv, with Stein staying on as CEO. Elligint, whose systems support care management for more than 13 million US policyholders, plans to double Laguna's team of about 20 people.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Finance AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

AI Funding Brief

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.